Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (5): 1341-1347.doi: 10.13481/j.1671-587X.20220530
• Methodology • Previous Articles Next Articles
Yeteng MU1,Chong GUO1,Nannan HU1,Fuxu YANG1,Han XUE1,Yuxin FAN1,Fenglin GUO1,Xingang GUAN1,2(
)
Received:2022-01-24
Online:2022-09-28
Published:2022-11-15
Contact:
Xingang GUAN
E-mail:guanxg@ciac.ac.cn
CLC Number:
Yeteng MU,Chong GUO,Nannan HU,Fuxu YANG,Han XUE,Yuxin FAN,Fenglin GUO,Xingang GUAN. Construction of immune checkpoint TIGIT lentivirus expression vector and establishment of cell line stably expressing TIGIT[J].Journal of Jilin University(Medicine Edition), 2022, 48(5): 1341-1347.
| 1 | HAANEN J B, ROBERT C. Immune checkpoint inhibitors[J]. Prog Tumor Res, 2015, 42: 55-66. |
| 2 | BRUNET J F, DENIZOT F, LUCIANI M F, et al. A new member of the immunoglobulin superfamily: CTLA-4[J]. Nature, 1987, 328(6127): 267-270. |
| 3 | AGATA Y, KAWASAKI A, NISHIMURA H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes[J]. Int Immunol, 1996, 8(5): 765-772. |
| 4 | 王明月, 王 浩, 王冬梅, 等. SIRPα-GFP真核表达载体构建及其在HEK293T细胞中的表达[J]. 吉林大学学报(医学版), 2020, 46(5): 925-929, 1111. |
| 5 | 刘宇轩, 黄莉莉, 杨馥旭, 等. LAG3慢病毒质粒构建及其稳定转染细胞系的建立[J]. 吉林大学学报(医学版), 2022, 48(1): 136-141. |
| 6 | WEISKOPF K. Cancer immunotherapy targeting the CD47/SIRPα axis[J]. Eur J Cancer,2017, 76: 100-109. |
| 7 | BAGCHI S, YUAN R, ENGLEMAN E G. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance[J]. Annu Rev Pathol, 2021, 16: 223-249. |
| 8 | YU X, HARDEN K, GONZALEZ L C, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells[J]. Nat Immunol, 2009, 10(1): 48-57. |
| 9 | LEVIN S D, TAFT D W, BRANDT C S, et al. Vstm3 is a member of the CD28 family and an important modulator of T-cell function[J]. Eur J Immunol, 2011, 41(4): 902-915. |
| 10 | 朱 伟, 张小勇, 张大千,等. 靶向适应性免疫治愈慢性乙型肝炎策略及进展[J].临床肝胆病杂志,2021,37(5):1016-1021. |
| 11 | STENGEL K F, HARDEN-BOWLES K, YU X,et al. Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering[J]. Proc Natl Acad Sci U S A, 2012, 109(14): 5399-5404. |
| 12 | JOLLER N, LOZANO E, BURKETT P R, et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses[J]. Immunity, 2014, 40(4): 569-581. |
| 13 | LI M, XIA P Y, DU Y, et al. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling[J].J Biol Chem, 2014, 289(25): 17647-17657. |
| 14 | 陈晓君, 刘彦权, 黄素蓉, 等. 母细胞性浆细胞样树突细胞肿瘤的研究进展[J].解放军医学杂志,2021,46(10):1040-1044. |
| 15 | JOHNSTON R J, COMPS-AGRAR L, HACKNEY J, et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function[J]. Cancer Cell, 2014, 26(6): 923-937. |
| 16 | 王 欣, 赵玉珠. 高龄甲状腺癌患者促甲状腺激素抑制方案对预后及T细胞免疫因子的影响研究[J].中国实用内科杂志,2021,41(11):978-980. |
| 17 | RECHES A, OPHIR Y, STEIN N, et al. Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity[J]. J Immunother Cancer, 2020, 8(1): e000266. |
| 18 | BOTTINO C, CASTRICONI R, PENDE D, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule[J].J Exp Med,2003,198(4):557-567. |
| 19 | LI Y C, ZHOU Q, SONG Q K, et al. Overexpression of an immune checkpoint (CD155) in breast cancer associated with prognostic significance and exhausted tumor-infiltrating lymphocytes: a cohort study[J]. J Immunol Res, 2020, 2020: 3948928. |
| 20 | YEO J, KO M, LEE D H, et al. TIGIT/CD226 axis regulates anti-tumor immunity[J]. Pharmaceuticals (Basel), 2021, 14(3): 200. |
| 21 | O’DONNELL J S, MADORE J, LI X Y, et al. Tumor intrinsic and extrinsic immune functions of CD155[J]. Semin Cancer Biol, 2020, 65: 189-196. |
| 22 | FREED-PASTOR W A, LAMBERT L J, ELY Z A, et al. The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer[J]. Cancer Cell, 2021, 39(10): 1342-1360.e14. |
| 23 | CHAUVIN J M, ZAROUR H M. TIGIT in cancer immunotherapy[J]. J Immunother Cancer, 2020, 8(2): e000957. |
| 24 | TOOR S M, SASIDHARAN NAIR V, DECOCK J,et al.Immune checkpoints in the tumor microenvironment[J]. Semin Cancer Biol, 2020, 65: 1-12. |
| 25 | POSTOW M A, CALLAHAN M K, WOLCHOK J D. Immune checkpoint blockade in cancer therapy[J]. J Clin Oncol, 2015, 33(17): 1974-1982. |
| 26 | STELMACHOWSKA-BANAŚ M, CZAJKA-ORANIEC I. Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review[J]. Endocr Connect, 2020, 9(10): R207-R228. |
| 27 | INOZUME T, YAGUCHI T, FURUTA J, et al. Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase[J]. J Invest Dermatol, 2016, 136(1): 255-263. |
| 28 | HU F, WANG W Q, FANG C H, et al. TIGIT presents earlier expression dynamic than PD-1 in activated CD8+T cells and is upregulated in non-small cell lung cancer patients[J].Exp Cell Res,2020,396(1): 112260. |
| 29 | ZHANG T, WANG J H, ZHOU X C, et al. Increased expression of TIGIT on CD4+T cells ameliorates immune-mediated bone marrow failure of aplastic anemia[J]. J Cell Biochem, 2014, 115(11): 1918-1927. |
| 30 | CHAUVIN J M, PAGLIANO O, FOURCADE J,et al. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients[J].J Clin Invest, 2015, 125(5): 2046-2058. |
| 31 | KURTULUS S, SAKUISHI K, NGIOW S F, et al. TIGIT predominantly regulates the immune response via regulatory T cells[J]. J Clin Invest, 2015, 125(11): 4053-4062. |
| 32 | ATTALLA K, FARKAS A M, ANASTOS H, et al. TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer[J]. Urol Oncol Semin Orig Investig, 2020,40(9):403-406. |
| [1] | Qiuyuan SU,Ling ZHAO,Jiajia TAN,Shien MO,Haiqin ZHOU,Fangfang LU,Yi WEI,Yang ZHOU,Yan KUANG. Construction of SPHK1 overexpression lentiviral vectors and establishment of stable transfected SKOV3 cell lines [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1709-1716. |
| [2] | Shengnan LI,Jiawen HE,Keqi LIAO,You LI. Construction of dedicator of cytokinesis 4 over-expressed lentivirus vector and establishment of stable transfected Neuro-2a cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1322-1329. |
| [3] | Jiawen HE,You LI,Keqi LIAO,Shengnan LI. Construction of EIF4A3 shRNA lentiviral vector and establishment of its stable transfection cell line [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 831-839. |
| [4] | WANG Mingyue, WANG Hao, WANG Dongmei, YANG Zebin, CUI Meiying, LIU Ning, HUANG Lili, GUAN Xingang. Construction of SIRPα-GFP eukaryotic expression vector and its expression in HEK293T cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(05): 925-929. |
| [5] | LYU Dong, LIANG Chunmei, LI Mingying, YIN Jingwen, LUO Xudong, LIN Juda, MA Guoda. Packaging and identification of miR-137 overexpression lentivirus [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 694-697. |
| [6] | WANG Xiao-feng,ZHOU Xiang-yu,ZHANG Gui-zhen,WANG Wei,DU Zhen-wu,ZHANG Tian-fu. Expression of enhanced green fluorescent protein gene regulatedby CD133 gene promoter in laryngocarcinoma Hep-2 cells [J]. Journal of Jilin University Medicine Edition, 2013, 39(3): 498-502. |
| [7] | FANF Yang-giu,LIU Lei,TAN Yan,JIANG Yong-xing. Construction of specific expression vector of EGFP regulated by ODDD in cells under hypoxia and its significance [J]. J4, 2012, 38(5): 870-875. |
| [8] | ZHAO Dong-Hai, ZHU An-Feng, YANG Shu-Yan, ZHONG Xiu-Hong, ZHANG Yi-Zhong, DIAO Li-Wei. Establishment of |marrow mesenchymal stem cells expressing rat NKX2.5-pEGFP fusion protein [J]. J4, 2011, 37(4): 670-674. |
| [9] | BAI Yuan-song,SUN Yan-xia,DIAO Jian-dong,LU Zhen-xia. Transduction efficiency of green fluorescent protein gene in leukemia cells K562 [J]. J4, 2009, 35(1): 135-137. |
| [10] | . [J]. J4, 2007, 33(5): 798-802. |
| [11] | SHEN Xiao-mei,ZHANG Ju-yan,CHENG Bei. Construction of rat CnA/EGFP recombinant eukaryotic gene coexpression plasmid [J]. J4, 2007, 33(1): 25-28. |
| [12] | LIANG Shuang,YU Zhen-xiang, ZHAO Dan, YANG Ke, ZHAO Xue-jian, YANG Bao-xue. Reconstruction of aquaporin 8 and green fluorescentprotein fusion recombinant vector [J]. J4, 2006, 32(2): 218-220. |